Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

MSL Talk

Has the MSL Role Become Obsolete?

Jun 16, 202628 minVideo
ShareXLinkedInFacebookWhatsAppEmail

In this episode, Carolyn Reever joins the discussion about the evolving landscape of the Medical Science Liaison (MSL) role. They examine whether the MSL role is becoming obsolete amid changes in the pharmaceutical and biotech sectors. The dialogue addresses the impact of AI on the role, including how AI tools are transforming productivity and what key skills future MSLs will require. They stress the importance of keeping up with technological advancements and forecast the future demand for MSLs. Carolyn shares her predictions for the MSL role over the next decade, concluding with final thoughts and reflections.

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Transcript

From the show.

0:00Hey, guys. Welcome to the MSL talk podcast. Super excited. I have my dear friend Carolyn Rieber here to join us. Carolyn, welcome to the show. Yeah. So great to be here with you, Tom. Excited. We've been talking about this for a while. So Carolyn and I know each other for quite a while, and fun fact, she lives in Boca Raton, Florida, which as you guys know, I have a house in Boca Raton, Florida. So we're kind of neighbors in a way, kind of, sort of. What we decided to talk about today is is the MSO role becoming obsolete?

0:37And I get this question a lot. A lot of people go to conferences. There's a lot of chatter about the future of medical affairs. So Carolyn's gonna share her thoughts on that. But before we get into it, Carolyn, why don't you do an intro and tell everybody who you are and all that good stuff? Tom, really great to have the opportunity to be with you here today. So been in medical affairs for over twenty years and really have had the privilege over this time period of architecting and building scientific scientific platforms, building

1:12medical teams and field teams from the ground up, and all the while driving 11 product launches along the way. And, you know, there's been a lot of change during that time period, speaking today about about change. And one thing I think has really remained constant, it's it's the field medical organization as a strategic engine of an organization. And I'm really thrilled to dive today into why why that engine is more vital than than ever.

1:47Yeah. Yeah. And as we jump into this, I wanna give a shout out. So, you know, I I look at the the rankings each week as they come out, and this podcast is actually doing incredibly well in Italy. So shout out to my friends in Italy. As you guys know, I am part Italian, half Italian, half Portuguese. But shout out to our friends in Italy. We're number six in the careers category in Italy this week, so had to mention that.

2:19But getting into the topic itself, I think I think we should start with the question, in your opinion, is the MSL role becoming obsolete? Let's get right to it. Throw it right in. Yeah. I love starting with a provocative question Yeah. Like that. You know, is the role of the MSL obsolete? And I'd say absolutely not. Absolutely not. It is more critical than ever. If we look really over, you know, the past fifteen years of of the MSL role, it the MSLs

2:54were often viewed as an extension of their sales colleagues, brought in to answer questions, solve tough problems that were happening, you know, in a physician office or or with a KOL. And today, the industry has fundamentally shifted. We're navigating really high complex science, and it's no longer about answering questions. It's about developing and advancing a scientific journey.

3:27It's about delivering precise and targeted medical education and capturing deep medical insights. And that's really, you know, enabling medical affairs to be more of a strategic pillar, a premier independent pillar of leadership within an organization. So not really a nice to have anymore. Mhmm.

3:58And, you know, I think when when I think about the organizations that are leading this charge, that are looking to be on the leading edge, you know, they're realizing that it's not this nice to have support function. It's a business critical priority to really advance the understanding and enablement of of a new asset or an existing product. And I would say that the MS community the MSLs and and MSL leaders that are listening to this

4:29right now are are nodding their heads in agreement and saying, 100%. I think we are all in agreement Yeah. That the role has evolved to a point of absolute necessity, and I don't see it getting I don't see it as obsolete, or I don't think it will be obsolete anytime soon. So, yeah, a little bit of a clickbaity title there, but I think it's a great conversation because there is a lot going on.

4:59There's a lot coming at us in medical affairs. The MSO role is and has evolved, as I said. So let's talk about kinda where we are and and where you see the pharmaceutical biotech industry today compared to, like, maybe ten or fifteen years ago. Yeah. And and today, it's really that explosion of science. A lot of the new therapeutic areas that are that are expanding into the new therapies, we're talking about precision medicine.

5:29We're talking about gene therapy, and the diagnostic aspects are really exploding as well, right, in oncology and in some of the gene therapies as well. So so I I think with that with that piece of the scientific complexity getting so much higher, I think that that's really where the the that plays into the MSL's core strength. It's that high science and being able to translate that high science into a peer to peer

6:04relationship, into a peer to peer dialogue with a clinician, with a thought leader, and with other practitioners that are really, you know, really at the forefront of of why the MSL role is so critical. And it it creates the argument too. It's it's the argument for why MSLs are so valuable because the the stakes are so much higher. The the science, the innovation, it's all at a whole another level, and it's it's moving at

6:36such a different I think, such a different pace now than I think ever before. In order for the healthcare and medical community to keep up. MSLs are more valuable now than ever. Would you agree with that? Yeah. I I absolutely think that that is the case. More more valuable and and probably more agile than we had been in the past, where kinda going

7:08back to what what I said at at the beginning where, you know, MSLs brought in to address tough questions. They were kind of in this reactive mode. Now there's a cadre of different activities that MSL needs to be able to advance, whether it's a discussion with a thought leader, maybe a, you know, excellence needing to have conversations and desired conversations with genetic counselors, with nurse practitioners, etcetera, delivering education.

7:40And that all important topic of medical insights that we like to spend a lot of time talking about. Right? I think the how I think I've experienced firsthand, you know, as as a global therapeutic head, why that becomes so critical and really how those insights really help us evolve our strategy, help us evolve the education that we really need to bring forward these novel therapies, these, therapies that are really changing the therapeutic landscape, and it

8:13really comes down to that core capability of the MSL being a strategic part of that. Yep. Yeah. And, obviously, not all medical affairs organizations are the same. What's that expression? If you've seen one medical affairs organization, you've seen one. Right? Yeah. Yeah. But what happens when organizations underinvest in medical affairs or field medical support? Yeah. Yeah. And and so I think when when that happens, that's when we see the the actions of, you

8:49know, maybe more reactivity coming into play. When when I think about the underinvestment, it's it it really pulls forward a more reactive mode, sometime a more defensive mode, definitely on the part of of some of the leaders within the organization. And I think what I've also experienced is it can be a time where leadership gets more focused on metrics that maybe aren't the ones that really are needed to drive the

9:22organization. So I think it's really that, you know, enablement that, the field leadership teams need to be thinking about, our medical leadership teams need to be thinking about overall to really secure the resourcing, not only people resourcing, but capabilities resourcing to really enable our teams. So speaking of enabling, I can't not get into the AI.

9:55You know, elephant in the room if you as we talk about the future of the MSL. So how do you see artificial intelligence affecting the MSL role? And and do you think it eventually replaces it? Yeah. So another loaded question here today, Tom. We're not we're not shying away from from the tough questions. Right? So so, absolutely, I I see AI as a substantial enablement tool for medical affairs?

10:27And absolutely not. I do not see AI replacing the MSL. And and let me tell you why. I mean, I I really see AI as as being a tool to streamline our effectiveness. Tools like AI based next best action, the synthesis of massive clinical datasets to understand shifts in the paradigm of of treatment.

10:59I I think that the we're already starting to see AI based tools such as these really come into come into play. And so I think it'll help the MSLs be super planners. Right? Really plan that next or that that, interaction that they are intending to have much more efficiently and and much more effectively. And, you know, kind of really going back to your question about replacement of of the MSL,

11:33you know, the MSL is really the individual that synthesizes the relationship. AI synthesizes the information. MSLs synthesize the relationship. And we really can't automate the building of of human trust, deep emotional intelligence, and, you know, navigating the nuances of a of a peer to peer relationship. And I think that's really the place that the MSL excels at.

12:03Yeah. And I don't think that gets replaced anytime soon, if ever, because machines can't do that. Yeah. So, you know, I think that the job security for the MSL role is the ability to continue to develop those really strong relationships and even be able to bring insights back because that's another thing that would be hard for a machine to do. But what would you say as far as let's talk about the productivity aspect of Mhmm.

12:35AI AI tools and use cases. Like, what do you think the day to day changes might look like over the course of, I don't know, even the next, like, five years in the role because there's so many tools available. Yeah. I I think that's a that's a really important aspect. You know, when we think about the the investment so so I think, first of all, an individual MSL level, having the agility to navigate all of these different tools and

13:07learnings that the organizations are going to be having is gonna be critical. Right? So MSLs are gonna need to do a little bit of test and learn, with the tools that they're provided and give feedback, see what works, see what doesn't work. Organizations are really feel also need to be in this kind of test and learn, taking feedback, trying different tools, to really help enable their organizations in the most efficient ways. And we, you know, we we're all using ChatGPT.

13:41We're all using Google Gemini. Right? Outside of the organizational constraints, I think the organizations also have to get comfortable with, you know, what tools and and investing in the tools that, are really gonna enable the capabilities. And so if we think about these tools in speeding up all of the research, all of the pre call planning that an MSL needs to do to to get to that meeting. It it just means that they're more productive to be able to do other things.

14:15And I think the the the promise too becomes with as we invest in some of these digital enablement tools, the AI based tools, it really can help the MSL to really be that, more focused, strategic, medical individual to engage with physicians and health care systems to ultimately change the paradigms, that we're really looking to change for in medicine with

14:46the new therapies. Yeah. And getting back to this idea of as we look at automation, let's just say, as we look at AI and and productivity tools and automation. We talk about how it's gonna be impossible to replace the relationship building aspect. So what else because, you know, MSLs come to me all the time asking me, how do I stand out or what Mhmm. What makes a top performing MSL? So what parts of the of the MSL role are going to be impossible to replace, and what should

15:21MSLs be focusing on as we evolve? Yeah. So we talked about the relationship, really, you know, being that that synthesizer of of of relationships. I also think that it becomes with being able to translate that complex complex science. So that complex science still needs to be translated into a format that is easy to understand and communicate. I think we all know that physicians you know, the medicines have become more complex.

15:56Physicians' time has become even more of a commodity. And so really being able to to translate that complex science, having a deep understanding of it, having a deep understanding of the scientific narrative, and bringing that forward in a concise manner, and perhaps in a digital manner, being being responsive in a different way besides Teams, besides Zoom to to really secure that relationship and provide the the

16:30the information that the clinicians need to really drive clinical care. Yeah. And when you're so as as a as a medical affairs leader, as you're hiring folks and interviewing folks, what skills do you look for in MSLs now? And what do you think what do you think is gonna be important for the future MSL? Yeah. So so some of the things I think kind of going back to how we started really haven't changed.

17:07When I interviewed for MSL roles years ago, had folks coming into small organizations, I was looking for agility. I I was always looking for folks that could demonstrate agility because there were so many different dynamics of the role. So I think that that hasn't changed. I think where the agility, piece has probably gotten to a different level for me because when I think about agility, I was thinking about agility at a personal interaction level, maybe

17:43an emotional intelligence level. I think today, because of the tools available to us, we also need agility and resource resourcefulness around technology. So I think, really, it becomes, I think, an openness less about I know everything now, and I need to be able to either share it, use it, or translate it. And and more becomes a a openness to embracing new technology and learning along the way.

18:17So I think it's, you know, agility in a different way. It's really that dedication and and openness to to continue continuing to learn and evolve that's really been now in place for me. Yeah. You know, you mentioned technology. It's it's it's such an interesting time now. I think that we've gotten to a place where being technically savvy to at least a certain degree has almost become mandatory in the MSL role.

18:50And I think that the MSLs that are very technical may have an advantage over MSLs that that aren't. What what is your thought on keeping pace with technology and how that affects the the performance of an MSL? I I think that's a really interesting point. I I think this goes for medical affairs as a whole, as we are are seeing, you know, more

19:24folks coming into the workplace too that are digital natives. Right? I think while, you know, many folks within medical affairs were not digital natives. So it comes back into this. Yes. I think digital natives can can have an advantage, though at the same time, it's it's that acumen and the agility of someone who may not be a digital native to really bring forward that desire to learn and get better. Right? So because if we go back, I think, to the relationship building as being really the core

19:58piece, I think that that's that's also, you know, a place where we we need individuals to land. Because if somebody's really technically acumen is is very high and the relationship, you know, acumen is is low, they're not gonna be successful in the MSL role either. So I think it's really a combination of that that digital acumen and and emotional intelligence. Yeah. I agree. I think that, there certainly there certainly needs to be that combination.

20:30And like any like, when we talk about the the MSO role, it's it it can't be one thing. It you know, we've evolved to a point where MSLs need to be multifaceted. The skill level and the skill mix, has to be a combination of things. It can't just be one thing. So I think that as we look at the evolution of the role, it's gotten to this place where I think it's it's really more advanced than I think it's it's it's ever been.

21:03I think that it's evolved into really a super performer in a lot of ways. Am am I over exaggerating that? I don't think so. You know, I I I've always thought that the MSL role is one of the best in the industry anyway. Though, you know, given today's, you you know, high science modalities, I I think just really super performer is is a place where that we can really be thinking about this this role.

21:37Yeah. So yeah. Yeah. I mean, when when typically, we get opportunities from our clients. You know, they they ask us for the same type of skill set. Need good communicators. We need highly scientific individuals, maybe with an advanced degree. You know, we need great communicators, presenters, relationship builders. And now you have to think about adding that the other layers of not just emotional intelligence, but technology.

22:09So that's why I say that because Mhmm. I think the role continues. There's more and more things that the MSL can do, needs to do, and should do. Mhmm. Looking ahead, do you based on everything we're talking about, do you think that there's gonna be a greater demand for MSLs, less of a demand? What are your thoughts on the future and the demand for MSLs in industry.

22:42Yeah. I I I really see the the demand increasing and evolving at the same time, and it goes back to the to the the complexity of the science. Right? So as the complexity of our medicines have been increasing, I think the demand for highly technical MSLs who can engage, translate the science is increasing. And then I think the evolution really comes to as we bring in these enablement tools such as

23:15AI, the the opportunity to evolve to a strategic a strategic individual within the organization, really part of this strategic enterprise for for a medical organ a medical organization that really creates more space and time for the MSL to get involved in real world data generation, to get more involved in in, health care systems and the processes that

23:49they're enabling with their data and digital systems to improve patient care. So getting more strategically involved, is the place that I really see the MSL bringing forward with the advancement of these of these digital tools. Yeah. I think, again, this is another collective sigh of relief. I think everyone that just heard the answer to that question is like, is relieved because, you know, there are so many jobs that are maybe not getting replaced, but there's less there's

24:25there's not an increase. There's definitely a decrease in the amount of certain jobs available because of AI. So to hear you say and I agree. I do I do agree. Maybe I'm biased because I'm in this business as well, but I I do agree that I think the role is going to increase. I don't think it's gonna decrease. I think the value is gonna get greater and greater. I think there's gonna be more opportunity in in the near future. And I think that the reason I believe that is everything that we just talked about, you know,

24:59in this in this episode. The question though, it becomes and I'm gonna put you on the spot a little bit, as if I have it already. But if we were to revisit this conversation ten years from now, what do you think that the MSO role will look like at that time? Yeah. You know, I think medical affairs has historically, even over the past ten to fifteen

25:30years, been a little slow to evolve. And, you know, when I look at the advent of these technologies and how digital technologies, AI based technologies, and how they've improved the the performance of of my teams, how they have streamlined the the backwork of the teams that that, you know, that the teams have needed to do. I I think it's going to allow medical affairs to really jump into a more hyper growth base.

26:07And I think if we can figure out with AI how to automate the information side of the job, then that's really going to be the accelerator of the work that we need to do. So so if we can start preparing today as a community for the reality of the information mastery side of the job getting streamlined, then we really need to be focusing on our our

26:41strategic thinking, our collaborative skills, and and our enablement skills with with different health systems and complex patient journeys to really be that strategic medical individual. I agree. And I I think that, you know, a lot of what we talked about today there's a little bit of guesswork. There's a little bit of opinion. I mean, that's that's what we get to do here is we get to Yeah. To share the gut feeling and the opinion.

27:13But I do think that your expertise and your vast experience in medical affairs, what you've been seeing is incredibly valuable. I and I I do I I'm on the same page. So there's two votes here. I don't know if there's any other votes out there, but you got two votes for for all of the positives that were mentioned here today. Yeah. And right here, right now, those are the votes that count because It's all that matters. The pod votes. We're on the two that are on the podcast. That's it.

27:43Well, Carolyn, thank you for joining me. This was awesome. Really glad that we got a chance to do this, and we'll have to it again sometime. Yeah, Tom. A lot of fun. Thanks so much for having me here today. Awesome. Well, guys, thanks again. Appreciate all your support. Thank you for sharing this show with others. It's really important, and I wouldn't be here without all of you guys tuning in every week and liking, commenting, sharing, and following along on LinkedIn. So appreciate you guys. Love you all, and see you next time. Thanks, Carolyn.

Open the transcript file

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. The Wrong Voices: How Bad Mentors Can Ruin Your Career

    Nov 17, 202628 minVideo

    What qualifies someone to influence your future? Tom Caravela explains why career guidance should be filtered through relevant experience, current knowledge, credibility, and objectivity. He examines the risks of...

    Listen to the audio

    Credit the people on this episode

  2. Hidden Secret to Career Happiness and Longevity

    Nov 3, 202635 minVideo

    What turns an industry contact into a long-term ally? In this episode, Tom Caravela and Ed Doherty look beyond transactional networking to the genuine friendships that can shape a career in medical affairs. They discuss...

    Listen to the audio

    Credit the people on this episode

  3. How to AI-Proof Your Career: The 4 Pillars of Career Success

    Oct 20, 202623 minVideo

    Becoming undeniable is Tom Caravela’s answer to building career security in the age of AI. He breaks down four pillars you can control: skills, experience, relationships, and brand. Tom explains how continuous learning...

    Listen to the audio

    Credit the people on this episode

  4. How Medical Affairs Influences Decisions that Matter

    Oct 13, 202638 minVideo

    What happens after an MSL submits an insight? In this episode, Tom Caravela and Cameron Tew examine how field observations create value only when organizations decide what to do next. They discuss shared definitions,...

    Listen to the audio

    Credit the people on this episode

  5. Stop Being Your Own Worst Enemy

    Sep 29, 202619 minVideo

    In this episode, Tom Caravela discusses common mindset traps that can hold Medical Science Liaisons and aspiring MSLs back. He covers how to move past worst-case thinking, overanalysis, concern about others’ opinions,...

    Listen to the audio

    Credit the people on this episode